JAC Advance Access published online on December 12, 2002
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkg049
© 2002 by The British Society for Antimicrobial Chemotherapy
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In Brief
1 Centro Nacional de Microbiología,
Instituto de Salud Carlos III, Carretera Majadahonda a Pozuelo,
Km. 2,
28220 Majadahonda, Madrid
* Corresponding author. E-mail: jcampos{at}isciii.es.
Received 21 May 2002
; revised 8 August 2002
; accepted 19 October 2002
The activities of nalidixic acid, ciprofloxacin, norfloxacin,
ofloxacin, pefloxacin, flerofloxacin, sparfloxacin, grepafloxacin,
gatifloxacin, moxifloxacin, trovafloxacin, levofloxacin and clinafloxacin
against a panel of Haemophilus influenzae strains
were assessed by three susceptibility testing methods: Etest, agar
dilution and the reference broth microdilution method using Haemophilus
test medium (HTM) in all cases. The panel included 62 clinical and
two reference H. influenzae strains; 32
had decreased susceptibility to ciprofloxacin (MIC
Keywords: Haemophilus influenzae, antibiotic
resistance, quinolones, susceptibility testing methods
Activities of 13 quinolones by three susceptibility
testing
methods against a collection of Haemophilus influenzae isolates
with different levels of susceptibility to ciprofloxacin: evidence
for
cross-resistance
2 Servicio
de Microbiología, Hospital Ramón y Cajal, Madrid,
Spain
0.12
mg/L) and 30 were susceptible to this antibiotic (MIC
0.06 mg/L). Both Etest and HTM agar
dilution results (r = 0.96; 86.61% and
82.1% of MICs within + one log2, respectively)
correlated well with the reference microdilution method. The MIC90 of
ciprofloxacin was 4.0 mg/L (range 0.007-32.0 mg/L). Trovafloxacin
activity was similar to that of ciprofloxacin but sparfloxacin,
grepafloxacin, ofloxacin, pefloxacin and flerofloxacin activities
were higher (with MIC values one log2 dilution lower
than ciprofloxacin). The least active were norfloxacin (MIC90 16
mg/L) and nalidixic acid (MIC90 128 mg/L).
Levofloxacin and moxifloxacin were more active than ciprofloxacin
(MIC90 2 mg/L); clinafloxacin and gatifloxacin
were the most active with an MIC90 of 0.25 mg/L. Cross-susceptibility
among all quinolones was observed (r > 0.9).
Resistance to ciprofloxacin was associated with a similar magnitude
of activity loss to other new and old quinolones. Ciprofloxacin
MIC determination should be sufficient to detect the decreased susceptibility
to the whole group of quinolones.![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Nakamura, K. Yanagihara, Y. Morinaga, K. Izumikawa, M. Seki, H. Kakeya, Y. Yamamoto, S. Kamihira, and S. Kohno Melting Curve Analysis for Rapid Detection of Topoisomerase Gene Mutations in Haemophilus influenzae J. Clin. Microbiol., March 1, 2009; 47(3): 781 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Perez-Vazquez, F. Roman, S. Garcia-Cobos, and J. Campos Fluoroquinolone Resistance in Haemophilus influenzae Is Associated with Hypermutability Antimicrob. Agents Chemother., April 1, 2007; 51(4): 1566 - 1569. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, N. Mariano, J. J. Rahal, C. M. Urban, and K. Drlica Quinolone-Resistant Haemophilus influenzae: Determination of Mutant Selection Window for Ciprofloxacin, Garenoxacin, Levofloxacin, and Moxifloxacin Antimicrob. Agents Chemother., November 1, 2004; 48(11): 4460 - 4462. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Roman, R. Canton, M. Perez-Vazquez, F. Baquero, and J. Campos Dynamics of Long-Term Colonization of Respiratory Tract by Haemophilus influenzae in Cystic Fibrosis Patients Shows a Marked Increase in Hypermutable Strains J. Clin. Microbiol., April 1, 2004; 42(4): 1450 - 1459. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Perez-Vazquez, F. Roman, B. Aracil, R. Canton, and J. Campos Laboratory Detection of Haemophilus influenzae with Decreased Susceptibility to Nalidixic Acid, Ciprofloxacin, Levofloxacin, and Moxifloxacin Due to gyrA and parC Mutations J. Clin. Microbiol., March 1, 2004; 42(3): 1185 - 1191. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Perez-Vazquez, F. Roman, B. Aracil, R. Canton, and J. Campos In Vitro Activities of Garenoxacin (BMS-284756) against Haemophilus influenzae Isolates with Different Fluoroquinolone Susceptibilities Antimicrob. Agents Chemother., November 1, 2003; 47(11): 3539 - 3541. [Abstract] [Full Text] [PDF] |
||||

